Skip to main content
Autobound logo

What Agilent's latest 10-Q says: 4 signals

Agilent filed its latest 10-Q with the SEC on Sep 1, 2026. It discusses cybersecurity investment, manufacturing issue and margin pressure.

Public (A)Biotechnology Research10,000+ employeesagilent.comLinkedIn

Filed
Sep 1, 2026
Filings
3
Signals
21

10-Q · latest 10

What Agilent's 10-Q filings say

  1. 10-Q

    Filed · 4 signals

    SEC EDGAR

  2. 10-Q

    Filed · 6 signals

    SEC EDGAR

Earlier 10-Q filings

Showing 10 of 21 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Agilent earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Q3 revenue up 7.3% to $1.88B, beating guidance with 14% EPS growthDelivered strong Q3 results with core revenue growth of 7.3% to $1.88 billion, exceeding the high end of guidance. Non-GAAP operating margin was 27.2% (excluding tariff refunds), 80 basis points ahead of guidance. Non-GAAP EPS of $1.56 (ex-refunds) represented robust 14% year-over-year growth. Growth was strong in the Americas (10%) and China (9%).
Ignite program drives 210 bps margin expansion, 200 bps pricing liftThe 'Ignite' company-wide operating system is delivering significant financial results, contributing approximately 200 basis points from strategic pricing in Q3, surpassing the full-year target. This initiative is credited with expanding operating margins by over 210 basis points year-over-year (excluding tariff refunds), demonstrating strong operating leverage and financial discipline across...
Executing enterprise AI strategy with OpenAI and BCG X partnersAgilent is moving its enterprise AI strategy into execution, mobilizing a partnership with OpenAI and BCG X. The focus is on transforming the commercial customer journey, manufacturing operations, and accelerating the software development life cycle. The company aims to create durable value by combining AI with its proprietary data and scientific knowledge.
China revenue rebounds, growing 9% on strong pharma and food demandChina experienced a notable rebound, growing 9% in Q3, significantly ahead of flat expectations. The growth was driven by strong execution with commercial accounts in the pharma and food end markets, including competitive wins with two leading CXOs. Momentum is expected to continue into year-end, with Q4 guidance for high single-digit growth.
Raising full-year core growth guidance to ~6% and EPS to ~$6.20Building on strong Q3 results, the company raised its full-year core growth guidance to a range of 5.8% to 6.0%, an increase of 65 basis points at the midpoint. Full-year EPS expectations were increased by $0.15 at the midpoint to a range of $6.18 to $6.21, implying 10% YoY growth for the full year.
Secured key competitive wins in China for CXO and PFAS testingAgilent's differentiated portfolio and service offerings led to several competitive wins in China. These include securing business with two leading CXOs, an enterprise service contract with a major local pharma customer, and being selected by a leading commercial testing lab for their PFAS testing needs over the competition.

Signal API · MCP

Track Agilent with the Signal API

One POST /v1/companies/enrich call with agilent.com returns Agilent 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"agilent.com","signal_types":["sec-10q"],"limit":20}'

Same industry

10-Q at related companies

Questions about Agilent 10-Q

When did Agilent file its latest 10-Q?
Agilent filed its latest 10-Q on Sep 1, 2026. The one before it was filed on Jun 1, 2026.
What did Agilent disclose in its latest 10-Q?
From the filing dated Sep 1, 2026: Agilent faces new compliance costs from SEC, EU, and China cybersecurity regulations.
What did Agilent say on its recent earnings calls?
Q3 FY2026: Q3 revenue up 7.3% to $1.88B, beating guidance with 14% EPS growth (dated Aug 26, 2026).
Where can I read Agilent's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1090872/000109087226000064/a-20260731.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →